AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning: Molecular Therapy - Methods & Clinical Development
Blood-brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration - ScienceDirect
Blood-brain barrier (BBB) in the context of CNS-targetting... | Download Scientific Diagram
Engineered AAV Vectors Cross Blood-Brain Barrier in Monkeys
Delivering Genes Across the Blood-Brain Barrier | www.caltech.edu
Beyond the Blood Brain Barrier: PHP.B Enters the Central Nervous System Via the LY6A Receptor
Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates | Nature Biomedical Engineering
Improved AAV could cross BBB and deliver gene therapies to brain
Sci. Pharm. | Free Full-Text | Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery
Dissertation or Thesis | DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER | ID: v692t684w | Carolina Digital Repository
Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles | Nano Letters
Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model: Molecular Therapy - Methods & Clinical Development
Delivering Genes Across the Blood-Brain Barrier - BioTechniques
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection - ScienceDirect
Crossing the blood-brain barrier with AAV vectors | SpringerLink
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids | PLOS ONE
A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases | EMBO Molecular Medicine
AAV9: a potential blood-brain barrier buster: Molecular Therapy
Researchers engineer AAV vectors to cross the blood-brain barrier
.png "AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy")
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy
Research – Gradinaru Lab
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
An adeno-associated virus vector penetrates the blood–brain barrier in non-human primates | Nature Biomedical Engineering
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment - ScienceDirect
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier in Advanced Science-河南大学国际合作与交流处暨港澳台事务办公室
